Methods for treating immunomediated diseases of the nervous system by administering a compound comprising agents that inhibit the activity of procineticin receptors
A compound selected from non-peptide antagonists of procineticin receptors of chemical structure (PC1) or (PC7) ** (See formula) ** for use in the treatment of immunomediated diseases of the central nervous system, peripheral nervous system and neuromuscular junction .Un compuesto seleccionado de antagonistas no peptídicos de receptores de procineticinas de estructura química (PC1) o (PC7) **(Ver fórmula)** para su uso en el tratamiento de enfermedades inmunomediadas del sistema nervioso central, el sistema nervioso periférico y unión neuromuscular.